首页 > 最新文献

Molecular and Cellular Endocrinology最新文献

英文 中文
4T1 breast cancer cells exposed to extracellular vesicles from MDA-MB-231 cells stimulated with Bisphenol A increase the growth of mammary tumors and metastasis in female Balb/cJ mice. 4T1乳腺癌细胞暴露于MDA-MB-231细胞胞外囊泡中,双酚A刺激雌性Balb/cJ小鼠乳腺肿瘤的生长和转移增加。
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-08-07 DOI: 10.1016/j.mce.2025.112641
Pablo Torres-Alamilla, Rocio Castillo-Sanchez, Pedro Cortes-Reynosa, Maria Sanchez-Juarez, Rocio Gomez, Eduardo Perez Salazar

Breast cancer is the most prevalent neoplasia in women worldwide. Triple negative breast cancer (TNBC) is a subtype characterized by the absence of estrogen receptor, progesterone receptor and HER2 expression. Bisphenol A (BPA) is a chemical used in the synthesis of polycarbonate plastics and epoxy resins and its intake is related with breast cancer progression. Extracellular vesicles (EVs) are vesicles released by cells that mediate intercellular communication. However, the role of BPA in the release of EVs mediating cancer progression in TNBC remains to be studied. We hypothesize that EVs from BPA-stimulated TNBC cells promote metastasis-related processes, tumor growth and enhanced metastasis in a breast cancer mouse model. This study aims to evaluate the functional role of EVs from BPA-stimulated TNBC cells in metastasis-related processes and breast cancer progression using "in vitro" 4T1 cells models and an "in vivo" breast cancer mouse model. Findings demonstrate that exposition of TNBC 4T1 cells to EVs from TNBC MDA-MB-231 cells stimulated with 1 μM BPA for 24 h (BPA-EVs) significantly increases migration, invasion and MMP-9 secretion, compared to 4T1 cells exposed to EVs from non-stimulated MDA-MB-231 cells (Ctrl-EVs). Furthermore, Balb/cJ mice inoculated in mammary fat pad with 4T1 cells exposed to BPA-EVs show mammary tumors with more weight and volume, and more metastatic nodules in lung and liver than Balb/cJ mice inoculated with 4T1 cells exposed to Ctrl-EVs. In conclusion, BPA-EVs represent a significant mediator of TNBC progression, which defining the EVs as a novel element through which BPA promotes breast cancer progression.

乳腺癌是全世界妇女中最常见的肿瘤。三阴性乳腺癌(Triple negative breast cancer, TNBC)是一种以缺乏雌激素受体、孕激素受体和HER2表达为特征的亚型。双酚A (BPA)是一种用于合成聚碳酸酯塑料和环氧树脂的化学物质,其摄入量与乳腺癌的进展有关。细胞外囊泡(EVs)是细胞释放的囊泡,介导细胞间通讯。然而,BPA在EVs释放介导TNBC癌症进展中的作用仍有待研究。在乳腺癌小鼠模型中,我们假设来自bpa刺激的TNBC细胞的ev促进了转移相关过程、肿瘤生长和增强转移。本研究旨在通过“体外”4T1细胞模型和“体内”乳腺癌小鼠模型,评估bpa刺激的TNBC细胞EVs在转移相关过程和乳腺癌进展中的功能作用。结果表明,与暴露于未受刺激的MDA-MB-231细胞(ctrl - ev)的EVs相比,将TNBC 4T1细胞暴露于1 μM BPA刺激的TNBC MDA-MB-231细胞(BPA- ev)的EVs 24 h显著增加了迁移、侵袭和MMP-9的分泌。此外,Balb/cJ小鼠在乳腺脂肪垫中接种4T1细胞暴露于bpa - ev后,其乳腺肿瘤的重量和体积比接种4T1细胞暴露于ctrl - ev后的Balb/cJ小鼠更大,肺和肝脏转移结节也更多。综上所述,BPA- ev是TNBC进展的重要介质,这将ev定义为BPA促进乳腺癌进展的新因素。
{"title":"4T1 breast cancer cells exposed to extracellular vesicles from MDA-MB-231 cells stimulated with Bisphenol A increase the growth of mammary tumors and metastasis in female Balb/cJ mice.","authors":"Pablo Torres-Alamilla, Rocio Castillo-Sanchez, Pedro Cortes-Reynosa, Maria Sanchez-Juarez, Rocio Gomez, Eduardo Perez Salazar","doi":"10.1016/j.mce.2025.112641","DOIUrl":"10.1016/j.mce.2025.112641","url":null,"abstract":"<p><p>Breast cancer is the most prevalent neoplasia in women worldwide. Triple negative breast cancer (TNBC) is a subtype characterized by the absence of estrogen receptor, progesterone receptor and HER2 expression. Bisphenol A (BPA) is a chemical used in the synthesis of polycarbonate plastics and epoxy resins and its intake is related with breast cancer progression. Extracellular vesicles (EVs) are vesicles released by cells that mediate intercellular communication. However, the role of BPA in the release of EVs mediating cancer progression in TNBC remains to be studied. We hypothesize that EVs from BPA-stimulated TNBC cells promote metastasis-related processes, tumor growth and enhanced metastasis in a breast cancer mouse model. This study aims to evaluate the functional role of EVs from BPA-stimulated TNBC cells in metastasis-related processes and breast cancer progression using \"in vitro\" 4T1 cells models and an \"in vivo\" breast cancer mouse model. Findings demonstrate that exposition of TNBC 4T1 cells to EVs from TNBC MDA-MB-231 cells stimulated with 1 μM BPA for 24 h (BPA-EVs) significantly increases migration, invasion and MMP-9 secretion, compared to 4T1 cells exposed to EVs from non-stimulated MDA-MB-231 cells (Ctrl-EVs). Furthermore, Balb/cJ mice inoculated in mammary fat pad with 4T1 cells exposed to BPA-EVs show mammary tumors with more weight and volume, and more metastatic nodules in lung and liver than Balb/cJ mice inoculated with 4T1 cells exposed to Ctrl-EVs. In conclusion, BPA-EVs represent a significant mediator of TNBC progression, which defining the EVs as a novel element through which BPA promotes breast cancer progression.</p>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":" ","pages":"112641"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144812130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia” [Mol. Cell. Endocrinol. 581 (2024) 112113] “BRAFV600E突变维持甲状腺乳头状癌的侵袭性需要下调初级纤毛”的更正[Mol. Cell.]。中西医结合杂志[j].中华医学杂志。2016,36(2):444 - 444。
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-07-31 DOI: 10.1016/j.mce.2025.112626
Cheng-Xu Ma , Xiao-Ni Ma , Jin-Jin Liu , Cong-Hui Guan , Ying-Dong Li , Nan Zhao , Dídac Mauricio , Song-Bo Fu
{"title":"Corrigendum to “The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia” [Mol. Cell. Endocrinol. 581 (2024) 112113]","authors":"Cheng-Xu Ma ,&nbsp;Xiao-Ni Ma ,&nbsp;Jin-Jin Liu ,&nbsp;Cong-Hui Guan ,&nbsp;Ying-Dong Li ,&nbsp;Nan Zhao ,&nbsp;Dídac Mauricio ,&nbsp;Song-Bo Fu","doi":"10.1016/j.mce.2025.112626","DOIUrl":"10.1016/j.mce.2025.112626","url":null,"abstract":"","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"608 ","pages":"Article 112626"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144765088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial dysfunction and defective quality control mechanisms in the kidney are not reversed by high-fat diet withdrawal in early obese mice. 早期肥胖小鼠的高脂饮食戒断不能逆转肾脏线粒体功能障碍和质量控制机制缺陷。
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-08-05 DOI: 10.1016/j.mce.2025.112635
Patrícia C Braga, Rui Vitorino, Rita Ferreira, Mariana Marques, Pedro F Oliveira, Anabela S Rodrigues, Marco G Alves

High fat diet (HFD) induces glomerulopathy and proximal tubule injury. The precise pathophysiological mechanisms triggering obesity-related kidney impairment remain elusive, especially after dietary correction. Male C57BL6/J mice (n = 15) were divided in: control group (CTR) fed with standard chow; a group fed with HFD for 200 days (28-29 weeks); and a group fed with HFD for 60 days (8-9 weeks) and then with standard chow (HFDt)(∼21 weeks). Biometric data and whole-body metabolism were assessed. Expression of genes associated with mitochondrial dynamics, mitochondrial complexes and antioxidant defenses were analyzed. Kidney homogenates enriched in mitochondria were prepared and characterized by mass spectrometry-based proteomics. Kidney tissue of mice fed HFD exhibited reduced PGC-1α expression, an imbalance between fusion (increased MFN1 and decreased OPA1) and fission (decreased FIS1 and DRP1) processes. The activity of mitochondrial complex I (CI) was increased, while activity of complex II (CII) was decreased in the kidney after HFD and HFDt. Antioxidant defense Manganese Superoxide dismutase (MnSOD) was decreased in the kidney of HFD, while Glutathione reductase (GR) increased, with both activities being restored upon dietary reversion. Proteomic analysis showed alterations in proteins associated with glutathione and glycine metabolism, fatty acid oxidation (FAO), and peroxisomal function. HFD negatively impacted kidney glutathione related proteins (Gsta3 and Gsr); however dietary correction reverted this condition. Acsm3 protein was downregulated in kidney after HFD and upregulated after dietary correction. Some machinery is shared by mitochondria and peroxisomes, with their network being crucial particularly under stress conditions. A HFD impaired kidney FAO in peroxisomes, as evidenced by downregulation of Pecr after HFD and HFDt. Dietary correction after early-obesity mitigates the systemic metabolic dysfunction and can attenuate mitochondria dysfunction but is unable to completely restore mitochondria dynamics and bioenergetics. The results highlight the integrity of mitochondrial network as a main point for targeted therapeutic strategies aimed at preventing the progression of kidney disease.

高脂肪饮食(HFD)可引起肾小球病变和近端小管损伤。引发肥胖相关肾损害的确切病理生理机制仍然难以捉摸,特别是在饮食纠正后。雄性C57BL6/J小鼠15只,随机分为:对照组(CTR)饲喂标准饲料;一组饲喂HFD 200 d(28-29周);另一组饲喂HFD 60天(8-9周),然后饲喂标准饲料(HFDt)(~ 21周)。评估生物特征数据和全身代谢。分析了线粒体动力学、线粒体复合物和抗氧化防御相关基因的表达。制备了富含线粒体的肾脏匀浆,并用基于质谱的蛋白质组学对其进行了表征。饲喂HFD的小鼠肾组织中PGC-1α表达降低,融合(MFN1增加,OPA1减少)和裂变(FIS1和DRP1减少)过程失衡。HFD和HFDt后,肾脏线粒体CI活性升高,CII活性降低。HFD组肾脏抗氧化防御锰超氧化物歧化酶(MnSOD)降低,谷胱甘肽还原酶(GR)升高,且两者活性均在饲料还原后恢复。蛋白质组学分析显示与谷胱甘肽和甘氨酸代谢、脂肪酸氧化(FAO)和过氧化物酶体功能相关的蛋白质发生了变化。HFD对肾谷胱甘肽相关蛋白(Gsta3和Gsr)有负面影响,但饮食纠正可以逆转这种情况。HFD后肾脏中Acsm3蛋白下调,饮食矫正后上调。线粒体和过氧化物酶体共享一些机制,它们的网络在压力条件下尤为重要。HFD损害了肾过氧化物酶体的FAO, HFD和HFDt后Pecr的下调证明了这一点。早期肥胖后的饮食矫正可以减轻全身代谢功能障碍,减轻线粒体功能障碍,但不能完全恢复线粒体动力学和生物能量学。这些结果强调了线粒体网络的完整性是预防肾脏疾病进展的靶向治疗策略的要点。
{"title":"Mitochondrial dysfunction and defective quality control mechanisms in the kidney are not reversed by high-fat diet withdrawal in early obese mice.","authors":"Patrícia C Braga, Rui Vitorino, Rita Ferreira, Mariana Marques, Pedro F Oliveira, Anabela S Rodrigues, Marco G Alves","doi":"10.1016/j.mce.2025.112635","DOIUrl":"10.1016/j.mce.2025.112635","url":null,"abstract":"<p><p>High fat diet (HFD) induces glomerulopathy and proximal tubule injury. The precise pathophysiological mechanisms triggering obesity-related kidney impairment remain elusive, especially after dietary correction. Male C57BL6/J mice (n = 15) were divided in: control group (CTR) fed with standard chow; a group fed with HFD for 200 days (28-29 weeks); and a group fed with HFD for 60 days (8-9 weeks) and then with standard chow (HFDt)(∼21 weeks). Biometric data and whole-body metabolism were assessed. Expression of genes associated with mitochondrial dynamics, mitochondrial complexes and antioxidant defenses were analyzed. Kidney homogenates enriched in mitochondria were prepared and characterized by mass spectrometry-based proteomics. Kidney tissue of mice fed HFD exhibited reduced PGC-1α expression, an imbalance between fusion (increased MFN1 and decreased OPA1) and fission (decreased FIS1 and DRP1) processes. The activity of mitochondrial complex I (CI) was increased, while activity of complex II (CII) was decreased in the kidney after HFD and HFDt. Antioxidant defense Manganese Superoxide dismutase (MnSOD) was decreased in the kidney of HFD, while Glutathione reductase (GR) increased, with both activities being restored upon dietary reversion. Proteomic analysis showed alterations in proteins associated with glutathione and glycine metabolism, fatty acid oxidation (FAO), and peroxisomal function. HFD negatively impacted kidney glutathione related proteins (Gsta3 and Gsr); however dietary correction reverted this condition. Acsm3 protein was downregulated in kidney after HFD and upregulated after dietary correction. Some machinery is shared by mitochondria and peroxisomes, with their network being crucial particularly under stress conditions. A HFD impaired kidney FAO in peroxisomes, as evidenced by downregulation of Pecr after HFD and HFDt. Dietary correction after early-obesity mitigates the systemic metabolic dysfunction and can attenuate mitochondria dysfunction but is unable to completely restore mitochondria dynamics and bioenergetics. The results highlight the integrity of mitochondrial network as a main point for targeted therapeutic strategies aimed at preventing the progression of kidney disease.</p>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":" ","pages":"112635"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144799643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic profiling of hypothalamic development in female rats 雌性大鼠下丘脑发育的转录组学分析。
IF 3.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-07-19 DOI: 10.1016/j.mce.2025.112616
Emily N. Hilz , Madeline Streifer , Tyler M. Milewski , Andrea C. Gore
The hypothalamic arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV) are critical regulators of reproductive function, energy balance, stress, and neuromodulation. These regions undergo substantial changes in neural and glial populations over development that enable the acquisition of adult functions. Although previous studies have examined developmental changes in specific hypothalamic cell populations or gene families, to our knowledge, none has comprehensively compared unbiased/bulk transcriptional profiles across key developmental stages in both the ARC and AVPV. In this study, we used 3′ targeted RNA sequencing to profile gene expression in the ARC and AVPV of female rats at infantile (P8), peripubertal (P30), and adult (P60) life stages. We conducted unbiased and a priori selected differential gene expression analyses, the latter genes selected for their roles in reproduction, metabolism, stress, and neuromodulation. We also measured serum hormones as an index of physiology. Developmental analyses revealed robust differential gene expression between the infantile and prepubertal periods in both the ARC and AVPV, with substantial transcriptional overlap between regions. Fewer and more region-specific transcriptional changes were observed during the transition to adulthood. Gene ontology (GO) analyses revealed coordinated developmental programming prior to puberty, including downregulation of developmental processes and upregulation of metabolic and regulatory pathways. In adulthood, the AVPV showed continued transcriptional remodeling, while the ARC remained comparatively stable. FSH emerged as the strongest hormonal correlate of a priori hypothalamic gene expression. These data provide a reference for understanding hypothalamic development and hormone–gene interactions across life stages in the female rat.
下丘脑弓状核(ARC)和腹侧脑室周围核(AVPV)是生殖功能、能量平衡、应激和神经调节的关键调节器。这些区域在神经和胶质细胞群的发育过程中经历了实质性的变化,从而能够获得成人的功能。虽然以前的研究已经检查了特定下丘脑细胞群或基因家族的发育变化,但据我们所知,没有一个研究全面比较了ARC和AVPV在关键发育阶段的无偏倚/大量转录谱。在这项研究中,我们使用3'靶向RNA测序来分析雌性大鼠在婴儿期(P8)、青春期前期(P30)和成年期(P60)的ARC和AVPV中的基因表达。我们进行了无偏和先验选择的差异基因表达分析,后者基因因其在生殖、代谢、应激和神经调节中的作用而被选择。我们还测量了血清激素作为生理指标。发育分析显示,ARC和AVPV在婴儿期和青春期前的基因表达存在显著差异,区域之间存在大量转录重叠。在向成年期过渡期间,观察到的区域特异性转录变化越来越少。基因本体论(GO)分析揭示了青春期前的协调发育程序,包括发育过程的下调和代谢和调节途径的上调。在成年期,AVPV表现出持续的转录重塑,而ARC保持相对稳定。卵泡刺激素是与先天下丘脑基因表达最相关的激素。这些数据为了解雌性大鼠下丘脑发育和激素-基因相互作用提供了参考。
{"title":"Transcriptomic profiling of hypothalamic development in female rats","authors":"Emily N. Hilz ,&nbsp;Madeline Streifer ,&nbsp;Tyler M. Milewski ,&nbsp;Andrea C. Gore","doi":"10.1016/j.mce.2025.112616","DOIUrl":"10.1016/j.mce.2025.112616","url":null,"abstract":"<div><div>The hypothalamic arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV) are critical regulators of reproductive function, energy balance, stress, and neuromodulation. These regions undergo substantial changes in neural and glial populations over development that enable the acquisition of adult functions. Although previous studies have examined developmental changes in specific hypothalamic cell populations or gene families, to our knowledge, none has comprehensively compared unbiased/bulk transcriptional profiles across key developmental stages in both the ARC and AVPV. In this study, we used 3′ targeted RNA sequencing to profile gene expression in the ARC and AVPV of female rats at infantile (P8), peripubertal (P30), and adult (P60) life stages. We conducted unbiased and <em>a priori</em> selected differential gene expression analyses, the latter genes selected for their roles in reproduction, metabolism, stress, and neuromodulation. We also measured serum hormones as an index of physiology. Developmental analyses revealed robust differential gene expression between the infantile and prepubertal periods in both the ARC and AVPV, with substantial transcriptional overlap between regions. Fewer and more region-specific transcriptional changes were observed during the transition to adulthood. Gene ontology (GO) analyses revealed coordinated developmental programming prior to puberty, including downregulation of developmental processes and upregulation of metabolic and regulatory pathways. In adulthood, the AVPV showed continued transcriptional remodeling, while the ARC remained comparatively stable. FSH emerged as the strongest hormonal correlate of <em>a priori</em> hypothalamic gene expression. These data provide a reference for understanding hypothalamic development and hormone–gene interactions across life stages in the female rat.</div></div>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"608 ","pages":"Article 112616"},"PeriodicalIF":3.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144682811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking immune evasion in breast cancer by targeting COX-2/PGE2 pathway 靶向COX-2/PGE2通路打破乳腺癌免疫逃避
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-07-23 DOI: 10.1016/j.mce.2025.112617
Xuewei Zheng , Junxiang Wang , Yanan OuYang , Kaiyuan Yao , Jiayu Zheng , Li Zeng , Jingjing Wang , Hetao Chen , Haoming Du , Dongliao Fu , Linlin Shi , Anshun Zhao , Qinan Yin
The cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway plays a pivotal role in breast cancer (BC) progression by promoting immune suppression, tumor growth, and metastasis. PGE2 mediates these effects through EP receptors (EP1–EP4), suppressing anti-tumor immunity while fostering an immunosuppressive tumor microenvironment (TME). This includes the recruitment and activation of tumor-associated macrophages (TAMs), dendritic cells (DCs), cancer-associated fibroblasts (CAFs), myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs), ultimately impairing cytotoxic T lymphocyte and natural killer (NK) cell function. Targeting the COX-2/PGE2 axis presents a promising strategy for BC treatment. Dual inhibition of EP2 and EP4 has demonstrated superior efficacy in reversing immune suppression compared to single-receptor blockade. Additionally, combining EP4 antagonists with immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-CTLA-4 enhances T cell infiltration and tumoricidal activity, leading to improved therapeutic outcomes. Another emerging approach involves enhancing the activity of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), the key enzyme responsible for PGE2 degradation, to counteract PGE2-driven immune evasion. PTGES1 inhibitors have shown great potential in overcoming the immunosuppressive TME in BC patients. Elevated TIL levels in TNBC and HER2-positive BC are associated with improved prognosis; however, COX-2 inhibitors such as celecoxib failed to enhance survival and carry potential cardiovascular risks, highlighting the need for TIL-stratified trials to refine immunotherapeutic strategies. This review highlights the immunosuppressive mechanisms of the COX-2/PGE2 pathway in BC and explores novel therapeutic strategies targeting this axis. Understanding the intricate crosstalk between PGE2 signaling and immune modulation may lead to the development of more effective BC treatments, particularly in combination with immunotherapies.
环氧化酶-2 (COX-2)/前列腺素E2 (PGE2)通路通过促进免疫抑制、肿瘤生长和转移在乳腺癌(BC)进展中起关键作用。PGE2通过EP受体(EP1-EP4)介导这些作用,抑制抗肿瘤免疫,同时培养免疫抑制肿瘤微环境(TME)。这包括肿瘤相关巨噬细胞(tam)、树突状细胞(DCs)、癌症相关成纤维细胞(CAFs)、髓源性抑制细胞(MDSCs)和调节性T细胞(Tregs)的募集和激活,最终损害细胞毒性T淋巴细胞和自然杀伤细胞(NK)功能。针对COX-2/PGE2轴是一种很有前景的BC治疗策略。与单受体阻断相比,双重抑制EP2和EP4在逆转免疫抑制方面显示出更好的效果。此外,EP4拮抗剂与免疫检查点抑制剂(ICIs)如抗pd -1和抗ctla -4联合使用可增强T细胞浸润和肿瘤杀伤活性,从而改善治疗效果。另一种新出现的方法涉及提高15-羟基前列腺素脱氢酶(15-PGDH)的活性,这是负责PGE2降解的关键酶,以抵消PGE2驱动的免疫逃避。PTGES1抑制剂在克服BC患者的免疫抑制性TME方面显示出巨大的潜力。TNBC和her2阳性BC中TIL水平升高与预后改善相关;然而,COX-2抑制剂如塞来昔布未能提高生存率,并携带潜在的心血管风险,这突出了对til分层试验的需求,以完善免疫治疗策略。本文综述了BC中COX-2/PGE2通路的免疫抑制机制,并探索了针对该轴的新治疗策略。了解PGE2信号和免疫调节之间复杂的串扰可能会导致更有效的BC治疗的发展,特别是与免疫疗法的结合。
{"title":"Breaking immune evasion in breast cancer by targeting COX-2/PGE2 pathway","authors":"Xuewei Zheng ,&nbsp;Junxiang Wang ,&nbsp;Yanan OuYang ,&nbsp;Kaiyuan Yao ,&nbsp;Jiayu Zheng ,&nbsp;Li Zeng ,&nbsp;Jingjing Wang ,&nbsp;Hetao Chen ,&nbsp;Haoming Du ,&nbsp;Dongliao Fu ,&nbsp;Linlin Shi ,&nbsp;Anshun Zhao ,&nbsp;Qinan Yin","doi":"10.1016/j.mce.2025.112617","DOIUrl":"10.1016/j.mce.2025.112617","url":null,"abstract":"<div><div>The cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway plays a pivotal role in breast cancer (BC) progression by promoting immune suppression, tumor growth, and metastasis. PGE2 mediates these effects through EP receptors (EP1–EP4), suppressing anti-tumor immunity while fostering an immunosuppressive tumor microenvironment (TME). This includes the recruitment and activation of tumor-associated macrophages (TAMs), dendritic cells (DCs), cancer-associated fibroblasts (CAFs), myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs), ultimately impairing cytotoxic T lymphocyte and natural killer (NK) cell function. Targeting the COX-2/PGE2 axis presents a promising strategy for BC treatment. Dual inhibition of EP2 and EP4 has demonstrated superior efficacy in reversing immune suppression compared to single-receptor blockade. Additionally, combining EP4 antagonists with immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-CTLA-4 enhances T cell infiltration and tumoricidal activity, leading to improved therapeutic outcomes. Another emerging approach involves enhancing the activity of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), the key enzyme responsible for PGE2 degradation, to counteract PGE2-driven immune evasion. PTGES1 inhibitors have shown great potential in overcoming the immunosuppressive TME in BC patients. Elevated TIL levels in TNBC and HER2-positive BC are associated with improved prognosis; however, COX-2 inhibitors such as celecoxib failed to enhance survival and carry potential cardiovascular risks, highlighting the need for TIL-stratified trials to refine immunotherapeutic strategies. This review highlights the immunosuppressive mechanisms of the COX-2/PGE2 pathway in BC and explores novel therapeutic strategies targeting this axis. Understanding the intricate crosstalk between PGE2 signaling and immune modulation may lead to the development of more effective BC treatments, particularly in combination with immunotherapies.</div></div>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"608 ","pages":"Article 112617"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RUNX3 drives HTR-8/SVneo cell ferroptosis and spontaneous abortion: involvement of the suppression of GDF15 transcriptional activity RUNX3驱动HTR-8/SVneo细胞铁下垂和自然流产:参与抑制GDF15转录活性。
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-07-23 DOI: 10.1016/j.mce.2025.112618
Lanlan Cheng, Jie Zhang, Yungai Xiang, Li Tan
Spontaneous abortion (SA) refers to the loss of a pregnancy without external intervention. The runt-related transcription factor 3 (RUNX3) is associated with gestational disorders in view of previous studies. However, RUNX3 has not been reported in SA. RUNX3 is significantly upregulated in the placental villi of abortion patients based on the GSE123719 microarray data. Herein, we further validated and found that the expression of RUNX3 in placental villi of SA women was higher than those of induced abortion (IA) women. In vitro, we constructed human RUNX3 overexpression or interference adenovirus vectors to modulate RUNX3 expression in trophoblast cells. Our findings revealed that RUNX3 overexpression accelerated trophoblast cell ferroptosis, while RUNX3 knockdown alleviated erastin-induced ferroptosis. Subsequently, the dual luciferase reporter assay was performed to confirm that RUNX3 bound to the GDF15 promoter to transcriptionally repress GDF15 transcriptional activity. Importantly, GDF15 attenuated the pro-ferroptosis effects of RUNX3 on HTR-8/SVneo cells. In vivo, mouse RUNX3 interference adenovirus vectors were used to silence RUNX3 in mice. The results presented that the reduction of RUNX3 inhibited embryo adsorption rate in SA mice, involving ferroptosis and the interaction between RUNX3 and GDF15. Taken together, this study established that RUNX3 advanced SA progression by enhancing trophoblast ferroptosis via transcriptionally repressing GDF15. These findings may provide novel therapeutic strategies for SA management.
自然流产(SA)是指在没有外界干预的情况下流产。根据以往的研究,矮小相关转录因子3 (RUNX3)与妊娠疾病有关。然而,RUNX3在SA中尚未报道。基于GSE123719芯片数据,RUNX3在流产患者胎盘绒毛中显著上调。我们进一步验证并发现RUNX3在SA女性胎盘绒毛中的表达高于人工流产(IA)女性。体外构建人RUNX3过表达或干扰腺病毒载体,调控RUNX3在滋养细胞中的表达。我们的研究结果显示,RUNX3过表达加速了滋养细胞铁下垂,而RUNX3敲低则减轻了erastin诱导的铁下垂。随后,进行双荧光素酶报告基因测定,证实RUNX3与GDF15启动子结合,转录抑制GDF15的转录活性。重要的是,GDF15减弱了RUNX3对HTR-8/SVneo细胞的促铁下垂作用。在体内,利用小鼠RUNX3干扰腺病毒载体沉默小鼠RUNX3。结果表明,RUNX3的降低抑制了SA小鼠胚胎吸附率,涉及铁下垂和RUNX3与GDF15的相互作用。综上所述,本研究证实RUNX3通过转录抑制GDF15促进滋养细胞铁下垂,从而促进SA进展。这些发现可能为SA的治疗提供新的治疗策略。
{"title":"RUNX3 drives HTR-8/SVneo cell ferroptosis and spontaneous abortion: involvement of the suppression of GDF15 transcriptional activity","authors":"Lanlan Cheng,&nbsp;Jie Zhang,&nbsp;Yungai Xiang,&nbsp;Li Tan","doi":"10.1016/j.mce.2025.112618","DOIUrl":"10.1016/j.mce.2025.112618","url":null,"abstract":"<div><div>Spontaneous abortion (SA) refers to the loss of a pregnancy without external intervention. The runt-related transcription factor 3 (RUNX3) is associated with gestational disorders in view of previous studies. However, RUNX3 has not been reported in SA. RUNX3 is significantly upregulated in the placental villi of abortion patients based on the GSE123719 microarray data. Herein, we further validated and found that the expression of RUNX3 in placental villi of SA women was higher than those of induced abortion (IA) women. <em>In vitro</em>, we constructed human RUNX3 overexpression or interference adenovirus vectors to modulate RUNX3 expression in trophoblast cells. Our findings revealed that RUNX3 overexpression accelerated trophoblast cell ferroptosis, while RUNX3 knockdown alleviated erastin-induced ferroptosis. Subsequently, the dual luciferase reporter assay was performed to confirm that RUNX3 bound to the GDF15 promoter to transcriptionally repress GDF15 transcriptional activity. Importantly, GDF15 attenuated the pro-ferroptosis effects of RUNX3 on HTR-8/SVneo cells. <em>In vivo</em>, mouse RUNX3 interference adenovirus vectors were used to silence RUNX3 in mice. The results presented that the reduction of RUNX3 inhibited embryo adsorption rate in SA mice, involving ferroptosis and the interaction between RUNX3 and GDF15. Taken together, this study established that RUNX3 advanced SA progression by enhancing trophoblast ferroptosis via transcriptionally repressing GDF15. These findings may provide novel therapeutic strategies for SA management.</div></div>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"608 ","pages":"Article 112618"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterogeneity of Sox2-expressing cells in mouse pituitary and their roles in postnatal gonadotroph differentiation. 小鼠垂体中sox2表达细胞的异质性及其在出生后促性腺分化中的作用。
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-08-05 DOI: 10.1016/j.mce.2025.112638
Kosara Smiljanic, Stephanie Constantin, Naseratun Nessa, Stanko S Stojilkovic

Postnatal differentiation of gonadotrophs from Sox2-expressing stem cells is essential for maturation of the hypothalamic-pituitary-gonadal axis, puberty, and reproduction. Here, we examined the differentiation and maintenance of gonadotrophs in developing and adult mice. Gonadotrophs and Sox2-expressing cells were identified by immunostaining, and gonadotrophs were also visualized by specific expression of the fluorescent protein tdTomato during embryonic and postnatal differentiation. Sox2-expressing cells are localized in the anterior parenchyma, marginal zone, and posterior pituitary, regardless of mouse age. Gonadotrophs are localized in the anterior parenchyma separate from Sox2-expressing cells. During the juvenile and prepubertal periods, cells in transition from Sox2 expression to tdTomato expression, as well as numerous differentiated gonadotrophs, were also present in the marginal zone. The size and distribution of the newly differentiated gonadotrophs were consistent with their migration into the parenchyma and maturation into a secretory cell type. Specific knockout of PI4-kinase A in gonadotrophs slowed their postnatal differentiation in the marginal zone, causing a significant reduction in the size of the gonadotroph population. This was accompanied by a progressive loss of specific gene expression in the residual gonadotrophs, leading to an increase in the number of dedifferentiated cells expressing tdTomato. Thus, Sox2 expressing cells in the marginal zone serve as stem cells for postnatal gonadotrophs, and the differentiation and maintenance of these cells require phosphoinositides derived by PI4-kinase A.

从表达sox2的干细胞中分化促性腺细胞对下丘脑-垂体-性腺轴、青春期和生殖的成熟至关重要。在这里,我们研究了促性腺激素在发育和成年小鼠中的分化和维持。通过免疫染色鉴定促性腺激素和表达sox2的细胞,并通过荧光蛋白tdTomato在胚胎和出生后分化过程中的特异性表达来观察促性腺激素。表达sox2的细胞定位于前实质、边缘区和垂体后叶,与小鼠年龄无关。促性腺激素定位于与sox2表达细胞分离的前实质。在幼年期和青春期前,边缘区也存在Sox2向tdTomato表达转变的细胞,以及大量分化的促性腺激素。新分化的促性腺细胞的大小和分布与它们向薄壁组织迁移和成熟为分泌型细胞相一致。在促性腺激素中特异性敲除pi4 -激酶A会减缓其出生后向边缘区分化,导致促性腺激素群体的大小显著减少。这伴随着残留的促性腺激素中特定基因表达的逐渐丧失,导致表达tdTomato的去分化细胞数量增加。因此,在边缘区表达Sox2的细胞作为出生后促性腺激素的干细胞,这些细胞的分化和维持需要pi4 -激酶A衍生的磷酸肌苷。
{"title":"Heterogeneity of Sox2-expressing cells in mouse pituitary and their roles in postnatal gonadotroph differentiation.","authors":"Kosara Smiljanic, Stephanie Constantin, Naseratun Nessa, Stanko S Stojilkovic","doi":"10.1016/j.mce.2025.112638","DOIUrl":"10.1016/j.mce.2025.112638","url":null,"abstract":"<p><p>Postnatal differentiation of gonadotrophs from Sox2-expressing stem cells is essential for maturation of the hypothalamic-pituitary-gonadal axis, puberty, and reproduction. Here, we examined the differentiation and maintenance of gonadotrophs in developing and adult mice. Gonadotrophs and Sox2-expressing cells were identified by immunostaining, and gonadotrophs were also visualized by specific expression of the fluorescent protein tdTomato during embryonic and postnatal differentiation. Sox2-expressing cells are localized in the anterior parenchyma, marginal zone, and posterior pituitary, regardless of mouse age. Gonadotrophs are localized in the anterior parenchyma separate from Sox2-expressing cells. During the juvenile and prepubertal periods, cells in transition from Sox2 expression to tdTomato expression, as well as numerous differentiated gonadotrophs, were also present in the marginal zone. The size and distribution of the newly differentiated gonadotrophs were consistent with their migration into the parenchyma and maturation into a secretory cell type. Specific knockout of PI4-kinase A in gonadotrophs slowed their postnatal differentiation in the marginal zone, causing a significant reduction in the size of the gonadotroph population. This was accompanied by a progressive loss of specific gene expression in the residual gonadotrophs, leading to an increase in the number of dedifferentiated cells expressing tdTomato. Thus, Sox2 expressing cells in the marginal zone serve as stem cells for postnatal gonadotrophs, and the differentiation and maintenance of these cells require phosphoinositides derived by PI4-kinase A.</p>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":" ","pages":"112638"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144799642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance 西马鲁肽对胰岛素抵抗肌管模型线粒体功能和胰岛素敏感性的影响
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-07-31 DOI: 10.1016/j.mce.2025.112629
Emmalie R. Spry, Kipton B. Travis, Kayla J. Ragland, Alexa J. Klein, John M. Zimmerman, Roger A. Vaughan

Aims

Semaglutide (SEMA) is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that has recently emerged as a popular pharmacological treatment for type 2 diabetes and insulin resistance due to its weight loss properties. Previous studies have examined the metabolic effects of SEMA using supra-pharmacokinetically (but not pharmacokinetically attainable) concentrations. The aim of the present study was to determine the metabolic effects of pharmacokinetically attainable levels of SEMA on mitochondrial function and metabolism, which are often reduced during insulin resistance.

Methods

C2C12 myotubes were treated for 24 h with SEMA at 10 nM which approximates pharmacokinetically attainable blood concentrations in vivo. Metabolic gene expression was measured using qRT-PCR. pAkt expression was assessed using Western blot. Seahorse metabolic assays were also used to measure mitochondrial and glycolytic metabolism. Fluorescent staining was used to assess mitochondrial and lipid content.

Results

Treatment with SEMA did not alter mitochondrial function, content, or related gene expression. Similarly, SEMA had no significant effect on glycolytic metabolism or related gene expression, nor did it alter cellular lipid content or lipogenic signaling.

Conclusions

High concentrations of SEMA may promote mitochondrial function during in vitro experiments, however the findings from the present report suggest pharmacokinetically attainable levels of SEMA do not alter myotube metabolism or expression of related molecular targets. Disparities in the present report and past observations may be a result of the lower concentrations of SEMA used in the present experiments. Further in vivo studies will be necessary to elucidate the full metabolic effects of SEMA on skeletal muscle.
SEMA (SEMA)是一种胰高血糖素样肽-1受体激动剂(GLP-1RA),由于其减肥特性,最近成为2型糖尿病和胰岛素抵抗的流行药物治疗。以前的研究已经使用超药代动力学(但不是药代动力学可达到的)浓度检测了SEMA的代谢作用。本研究的目的是确定药代动力学可达到的SEMA水平对线粒体功能和代谢的代谢影响,这在胰岛素抵抗期间通常会降低。方法sc2c12肌管用10 nM的SEMA处理24 h,该浓度接近体内药代动力学可达到的血药浓度。采用qRT-PCR检测代谢基因表达。Western blot检测pAkt表达。海马代谢测定也用于测定线粒体和糖酵解代谢。荧光染色测定线粒体和脂质含量。结果SEMA治疗未改变线粒体功能、含量或相关基因表达。同样,SEMA对糖酵解代谢或相关基因表达没有显著影响,也没有改变细胞脂质含量或脂肪生成信号。结论:在体外实验中,高浓度SEMA可能促进线粒体功能,但本报告的研究结果表明,可达到的SEMA药代动力学水平不会改变肌管代谢或相关分子靶点的表达。本报告与过去观察结果的差异可能是由于本实验中使用的SEMA浓度较低所致。进一步的体内研究将有必要阐明SEMA对骨骼肌的全面代谢作用。
{"title":"The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance","authors":"Emmalie R. Spry,&nbsp;Kipton B. Travis,&nbsp;Kayla J. Ragland,&nbsp;Alexa J. Klein,&nbsp;John M. Zimmerman,&nbsp;Roger A. Vaughan","doi":"10.1016/j.mce.2025.112629","DOIUrl":"10.1016/j.mce.2025.112629","url":null,"abstract":"<div><h3>Aims</h3><div>Semaglutide (SEMA) is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that has recently emerged as a popular pharmacological treatment for type 2 diabetes and insulin resistance due to its weight loss properties. Previous studies have examined the metabolic effects of SEMA using supra-pharmacokinetically (but not pharmacokinetically attainable) concentrations. The aim of the present study was to determine the metabolic effects of pharmacokinetically attainable levels of SEMA on mitochondrial function and metabolism, which are often reduced during insulin resistance.</div></div><div><h3>Methods</h3><div>C2C12 myotubes were treated for 24 h with SEMA at 10 nM which approximates pharmacokinetically attainable blood concentrations in vivo. Metabolic gene expression was measured using qRT-PCR. pAkt expression was assessed using Western blot. Seahorse metabolic assays were also used to measure mitochondrial and glycolytic metabolism. Fluorescent staining was used to assess mitochondrial and lipid content.</div></div><div><h3>Results</h3><div>Treatment with SEMA did not alter mitochondrial function, content, or related gene expression. Similarly, SEMA had no significant effect on glycolytic metabolism or related gene expression, nor did it alter cellular lipid content or lipogenic signaling.</div></div><div><h3>Conclusions</h3><div>High concentrations of SEMA may promote mitochondrial function during in vitro experiments, however the findings from the present report suggest pharmacokinetically attainable levels of SEMA do not alter myotube metabolism or expression of related molecular targets. Disparities in the present report and past observations may be a result of the lower concentrations of SEMA used in the present experiments. Further in vivo studies will be necessary to elucidate the full metabolic effects of SEMA on skeletal muscle.</div></div>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"608 ","pages":"Article 112629"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144766770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pirin knockdown alleviates the progression of metabolic dysfunction-associated steatotic liver disease by inhibiting hepatic lipid deposition, inflammation, and fibrosis Pirin敲低可通过抑制肝脏脂质沉积、炎症和纤维化来减轻代谢功能障碍相关脂肪变性肝病的进展。
IF 3.6 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-10-01 Epub Date: 2025-08-05 DOI: 10.1016/j.mce.2025.112632
Yujing Wang , Yuanxin Xu , Yilin Liu , Jindan Lin , Xincai Hong , Shuang Yan
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global disease with a broad spectrum of symptoms. Pirin (PIR) is involved in a variety of biological and molecular processes. However, the role of PIR in MASLD remains unclear. Rats were fed with high-fat and high-cholesterol (HFC) diet to induce MASLD. Time-course results showed that liver in HFC-fed rats exhibited a progressive increase in hepatic tissue damage over time (3, 6, and 9 weeks), and developed in obvious hepatic fibrosis and steatosis at week 9. Meanwhile, HFC feeding also gradually increased PIR expression in liver. In vitro, PIR expression was up-regulated in palmitic acid (PA)-induced Hep3B cells. PIR knockdown using PIR shRNA plasmid inhibited steatosis and expression of ACLY, FASN, and XBP1 in PA-induced Hep3B cells. Knocking down PIR inhibited hepatocyte inflammation by inhibiting phosphor-NF-κB p65 into the nucleus, which inhibited the expression of TNF-α and IL-1β. In MASLD, hepatocyte inflammation activates hepatic stellate cell, thereby leading to hepatic fibrosis. Supernatant from PA-treated Hep3B with PIR knockdown inhibited LX-2 activation, as evidenced by decreased expression of Col1A1 and α-SMA in LX-2 cells. Together, these results suggested that PIR knockdown might alleviate the progression of MASLD by inhibiting liver lipid deposition and inflammation, further inhibiting liver fibrosis. Transcriptome data analysis suggested that alteration in the expression of lipid metabolism-related pathways and genes might be a potential cause of PIR regulation in MASLD progression. These findings may reveal a novel target for MASLD therapy.
代谢功能障碍相关脂肪变性肝病(MASLD)是一种具有广泛症状的全球性疾病。Pirin (PIR)参与多种生物和分子过程。然而,PIR在MASLD中的作用仍不清楚。采用高脂高胆固醇(HFC)饲料诱导大鼠MASLD。时间过程结果显示,随着时间的推移(3,6和9周),hfc喂养大鼠肝脏的肝组织损伤逐渐增加,并在第9周出现明显的肝纤维化和脂肪变性。同时,HFC喂养也逐渐增加肝脏中PIR的表达。在体外,棕榈酸(PA)诱导的Hep3B细胞中PIR表达上调。在pa诱导的Hep3B细胞中,使用PIR shRNA质粒敲除PIR可抑制脂肪变性和ACLY、FASN和XBP1的表达。下调PIR通过抑制磷酸化nf -κB p65进入细胞核,抑制TNF-α和IL-1β的表达,从而抑制肝细胞炎症。在MASLD中,肝细胞炎症激活肝星状细胞,从而导致肝纤维化。PIR敲低pa处理Hep3B的上清液抑制LX-2的活化,LX-2细胞中Col1A1和α-SMA的表达降低。综上所述,这些结果表明PIR敲低可能通过抑制肝脏脂质沉积和炎症来缓解MASLD的进展,从而进一步抑制肝纤维化。转录组数据分析表明,脂质代谢相关通路和基因表达的改变可能是PIR调节MASLD进展的潜在原因。这些发现可能揭示了MASLD治疗的新靶点。
{"title":"Pirin knockdown alleviates the progression of metabolic dysfunction-associated steatotic liver disease by inhibiting hepatic lipid deposition, inflammation, and fibrosis","authors":"Yujing Wang ,&nbsp;Yuanxin Xu ,&nbsp;Yilin Liu ,&nbsp;Jindan Lin ,&nbsp;Xincai Hong ,&nbsp;Shuang Yan","doi":"10.1016/j.mce.2025.112632","DOIUrl":"10.1016/j.mce.2025.112632","url":null,"abstract":"<div><div>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global disease with a broad spectrum of symptoms. Pirin (PIR) is involved in a variety of biological and molecular processes. However, the role of PIR in MASLD remains unclear. Rats were fed with high-fat and high-cholesterol (HFC) diet to induce MASLD. Time-course results showed that liver in HFC-fed rats exhibited a progressive increase in hepatic tissue damage over time (3, 6, and 9 weeks), and developed in obvious hepatic fibrosis and steatosis at week 9. Meanwhile, HFC feeding also gradually increased PIR expression in liver. <em>In vitro</em>, PIR expression was up-regulated in palmitic acid (PA)-induced Hep3B cells. PIR knockdown using PIR shRNA plasmid inhibited steatosis and expression of ACLY, FASN, and XBP1 in PA-induced Hep3B cells. Knocking down PIR inhibited hepatocyte inflammation by inhibiting phosphor-NF-κB p65 into the nucleus, which inhibited the expression of TNF-α and IL-1β. In MASLD, hepatocyte inflammation activates hepatic stellate cell, thereby leading to hepatic fibrosis. Supernatant from PA-treated Hep3B with PIR knockdown inhibited LX-2 activation, as evidenced by decreased expression of Col1A1 and α-SMA in LX-2 cells. Together, these results suggested that PIR knockdown might alleviate the progression of MASLD by inhibiting liver lipid deposition and inflammation, further inhibiting liver fibrosis. Transcriptome data analysis suggested that alteration in the expression of lipid metabolism-related pathways and genes might be a potential cause of PIR regulation in MASLD progression. These findings may reveal a novel target for MASLD therapy.</div></div>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"608 ","pages":"Article 112632"},"PeriodicalIF":3.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144775791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of the RIPK4 enhances suppression of human melanoma growth through vitamin D signaling RIPK4的抑制通过维生素D信号传导增强了对人类黑色素瘤生长的抑制。
IF 3.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-09-15 Epub Date: 2025-06-07 DOI: 10.1016/j.mce.2025.112603
Bartlomiej Olajossy , Andrzej T. Slominski , Agnieszka Wolnicka–Glubisz
Downregulation of Receptor-Interacting Protein Kinase 4 (RIPK4) inhibits NF-κB and Wnt/β-catenin signaling in melanoma and xenograft growth in mice. The active form of vitamin D3 (1,25-D3), in addition to regulating calcium and phosphate metabolism in humans through the vitamin D receptor (VDR), can inhibit the NF-κB signaling pathway and can affect the proliferation and differentiation of normal and malignant cells, including melanoma. An hyperactive NF-κB pathway maintains the malignant behavior of melanoma, which can be influenced by both RIPK4 and activated VDR. As their interactions affecting the response to 1,25-D3 in melanoma have not been studied, we tested whether downregulation of RIPK4 affects the sensitivity of melanoma cells to 1,25-D3. Our results have shown that both siRIPK4 and CRISPR/Cas9-mediated RIPK4 knockout increase VDR expression in melanoma cells. Furthermore, a decrease in CYP24A1 expression and an increase in 1,25 D3-induced VDR levels were observed in cells with RIPK4 downregulation. Treatment with 1,25- D3 of RIPK4.KO cells, compared to their wild-type counterparts, significantly reduced proliferation in 2D and 3D culture (MTT or ATP assay) and decreased p-p65 and cyclin D1 levels in melanoma cells. These results indicate that RIPK4 knockout may enhance the therapeutic efficacy of 1,25-D3 against melanoma, which encourages further studies on targeting RIPK4 signaling for anti-melanoma effects in preclinical models.
受体相互作用蛋白激酶4 (RIPK4)下调抑制小鼠黑色素瘤和异种移植物生长中NF-κB和Wnt/β-catenin信号传导活性形式的维生素D3 (1,25-D3)除了通过维生素D受体(VDR)调节人体钙和磷酸盐代谢外,还可以抑制NF-κB信号通路,影响包括黑色素瘤在内的正常和恶性细胞的增殖和分化。过度活跃的NF-κB通路维持了黑色素瘤的恶性行为,这可能受到RIPK4和激活的VDR的影响。由于它们之间的相互作用影响黑色素瘤对1,25- d3的反应尚未被研究,我们测试了RIPK4的下调是否会影响黑色素瘤细胞对1,25- d3的敏感性。我们的研究结果表明,siRIPK4和CRISPR/ cas9介导的RIPK4敲除均可增加黑色素瘤细胞中VDR的表达。此外,在RIPK4下调的细胞中,CYP24A1表达降低,1,25 d3诱导的VDR水平升高。RIPK4的1,25- D3处理。与野生型相比,KO细胞在2D和3D培养(MTT或ATP测定)中显著降低增殖,并降低黑色素瘤细胞中的p-p65和cyclin D1水平。这些结果表明,敲除RIPK4可能会增强1,25- d3对黑色素瘤的治疗效果,这鼓励在临床前模型中进一步研究靶向RIPK4信号通路的抗黑色素瘤作用。
{"title":"Inhibition of the RIPK4 enhances suppression of human melanoma growth through vitamin D signaling","authors":"Bartlomiej Olajossy ,&nbsp;Andrzej T. Slominski ,&nbsp;Agnieszka Wolnicka–Glubisz","doi":"10.1016/j.mce.2025.112603","DOIUrl":"10.1016/j.mce.2025.112603","url":null,"abstract":"<div><div>Downregulation of Receptor-Interacting Protein Kinase 4 (RIPK4) inhibits NF-κB and Wnt/β-catenin signaling in melanoma and xenograft growth in mice. The active form of vitamin D3 (1,25-D3), in addition to regulating calcium and phosphate metabolism in humans through the vitamin D receptor (VDR), can inhibit the NF-κB signaling pathway and can affect the proliferation and differentiation of normal and malignant cells, including melanoma. An hyperactive NF-κB pathway maintains the malignant behavior of melanoma, which can be influenced by both RIPK4 and activated VDR. As their interactions affecting the response to 1,25-D3 in melanoma have not been studied, we tested whether downregulation of RIPK4 affects the sensitivity of melanoma cells to 1,25-D3. Our results have shown that both siRIPK4 and CRISPR/Cas9-mediated RIPK4 knockout increase VDR expression in melanoma cells. Furthermore, a decrease in CYP24A1 expression and an increase in 1,25 D3-induced VDR levels were observed in cells with RIPK4 downregulation. Treatment with 1,25- D3 of RIPK4.KO cells, compared to their wild-type counterparts, significantly reduced proliferation in 2D and 3D culture (MTT or ATP assay) and decreased p-p65 and cyclin D1 levels in melanoma cells. These results indicate that RIPK4 knockout may enhance the therapeutic efficacy of 1,25-D3 against melanoma, which encourages further studies on targeting RIPK4 signaling for anti-melanoma effects in preclinical models.</div></div>","PeriodicalId":18707,"journal":{"name":"Molecular and Cellular Endocrinology","volume":"607 ","pages":"Article 112603"},"PeriodicalIF":3.8,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144258550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular and Cellular Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1